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Fluorescent taxoids 
RK Guy’, ZA Scott*, RD Sloboda* and KC Nicolaoul 
Background: Taxol* is a natural product produced by the Pacific Yew, Taxus 
brevifolia, that has emerged as a prominent chemotherapeutic agent for the 
treatment of solid tumors. Taxol’s biochemical mode of action has been well 
studied: it binds to microtubules, stabilizing them and preventing their depoly- 
merization to tubulin subunits. At lower dosage levels, taxol also interferes with 
the normal dynamics of the tubulin-microtubule equilibrium. This biochemical 
effect causes taxol’s ultimate physiological effect, cell cycle arrest; taxol is 
thought to block anaphase A of mitosis. Taxol also causes a number of 
intriguing secondary effects on interphase cells that are poorly understood. We 
believed that a bio-active fluorescent taxol derivative could be a useful tool in 
the study of these cellular mechanisms, especially in interphase cells. 
Results: We have synthesized and characterized a series of stable, fluores- 
cently labeled derivatives of taxol that bind to microtubules and have cytotoxici- 
ties similar to that of taxol. Fluorescence microscopy experiments in interphase 
human foreskin fibroblast (HFF) cells indicate that one of these, a sulforhod- 
amine taxoid, is particularly well suited for optical microscopy. The use of this 
taxoid in HFF cells revealed a previously undetected localization of taxoids to 
the nucleolus during interphase. 
Conclusion: The production of a new fluorescent derivative of taxol provides a 
useful tool, enabling cellular biologists to study taxol’s mechanism of action. It 
is hoped that this material will prove particularly useful for the study of taxol’s 
effects upon interphase cells. 
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Introduction 
Taxol [1,2] (compound 1, Fig. 1) is an anticancer chemother- 
apeutic agent that was originally isolated in the late 1960’s 
by cytotoxicity-directed fractionation of the methanolic 
extracts of the bark of the Pacific yew, Tuxus brmifolia [3]. 
Although initial studies indicated that the new drug had 
considerable potential, development was delayed until the 
1980’s by the scarcity of the natural compound and its appar- 
ent lack of advantages over existing treatments [4]. The 
combination of early preclinical work at the National Cancer 
Institute (NCI) and the disclosure that taxol had an unusual 
biochemical mechanism (stabilization of microtubules) by 
Horwitz and coworkers [5,6], spurred on what became very 
rapid progression to taxol’s current status as a widely used 
clinical agent. Early on in the clinical trials, researchers 
observed that the drug had an unusual ability to repress 
both breast [7] and ovarian [8] cancers. The drug was also 
shown to have significant effects on several other types of 
solid tumors including non-small-cell lung and head-and- 
neck cancers [9]. 
The study of taxol’s mechanism of action has shed light 
upon the normal process of microtubule dynamics and 
gives insight into the importance of this process in cellu- 
lar events [lo]. Microtubules are crucial cellular struc- 
tures. They are composed of heterodimeric tubulin 
subunits that polymerize to form the multisubunit micro- 
tubule, a helical linear polymer 25 nm in diameter with a 
central 15 nm hole [11,12]. Normally, the microtubules of 
a cell are in a constant state of flux, growing and shrinking 
in a manner that has been characterized as ‘dynamic 
instability’ [13,14]. The dynamic properties of micro- 
tubules are central to many cellular processes, particularly 
the assembly and function of a mitotic spindle during cell 
division [15]. Tax01 stabilizes the microtubule, preventing 
‘catastrophe’ (the rapid depolymerization of the micro- 
tubule to free tubulin subunits) and reducing the ampli- 
tude and rate of the changes in microtubule length that 
are collectively known as ‘microtubule dynamics’ [16,17]. 
In cells, the biochemical effects of taxol ultimately lead 
to a strong inhibition of eukaryotic cell proliferation, 
usually blocking cell-cycle progression at the G,/Pro tran- 
sition into mitosis [18-201. At this time, the mterphase 
cytoskeleton is disassembled and the microtubules are 
reorganized into a bipolar array characteristic of the mitotic 
*Although in common usage for the last 20 years, Taxol is now a registered trademark of Bristol-Myers Squibb. The copyright of Bristol-Myers 
Squibb is recognized when Taxol or taxol is used in this article. 
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Structure of taxol, compound 1. The boxed substituents are crucial for 
biological activity. In reactions with electrophiles, the alcohol at the C2’ 
position is the most reactive and that at C7 is the second most reactive. 
apparatus. The drug also causes a number of cellular mor- 
phological changes in interphase cells [Zl-251, the most 
obvious of which is the formation of unusual bundles 
of microtubules [26-281. Often, these studies are carried 
out using optical fluorescence microscopy with either 
anti-tubulin immunofluorescence or fluorescently labeled 
tubulin. These techniques require fixation and permeabi- 
lization or microinjection, respectively. We envisaged that 
a bioactive fluorescently labeled derivative of taxol, able 
to cross the cell membrane, would facilitate the use of 
fluorescence microscopy techniques. We also expected 
that such a taxoid would allow the study of previously 
unprobed areas, such as taxol localization in cells or the 
presence of a secondary receptor for the drug. In particu- 
lar, we hoped that such a compound would stimulate work 
aimed at understanding taxol’s effects upon the interphase 
portion of the cell cycle. 
Before this project was begun, no fluorescent derivatives 
of taxol suitable for fluorescence microscopy had been 
reported. Kingston [29] had briefly mentioned, with little 
experimental detail, the production of a C-7 conjugated 
dansyl derivative of taxol, and Georg and coworkers [30] had 
reported the production of a sidechain analog of taxol, sub- 
stituting the weakly fluorescent m-dimethylaminobenzoyl 
group for the normal benzoyl at the C-3’-nitrogen, and its 
use to study the polarity of the binding site microenviron- 
ment. Very recently two groups have reported the prepara- 
tion of fluorescently labeled taxol [31] and taxotere [32] 
analogs designed for microscopy. 
The design of our targeted derivatives and choice of a 
synthetic pathway to these compounds followed the 
outline shown in Figure 2. To allow us to choose the best 
fluorophore, and to provide a method for linking other 
spectroscopically active groups (such as those used to 
enhance magnetic resonance imaging (MRI) and positron 
emission spectroscopy (PET)), we wished to make all of 
l :R=H 




3: R = carboxybenzoyl 
4:R=H 
Synthesis of the common reactive intermediate 4. Reagents and 
conditions: (a) benzyl chloroformate (60 eq. in 10 eq. portions), 
pyridine (110 eq.), methylene chloride, 25 “C, 70 %; (b) N-CBz-P- 
alanine (4.4 eq.), dicyclohexylcarbodiimide (4.4 es.), 4-(dimethy-l- 
amino)pyridine (1 eq.), 25 “C, 18 h, 95 O/o; (c) H,, 10 O/o Pd(C) 
(5 wt. o/o), MeOH, 25 “C, 2 h, quant. 
the desired derivatives using a common reactive inter- 
mediate, containing an easily conjugated center. We 
therefore considered taxol’s structure-activity relationship 
(SAR) [1,2,33] and its known patterns of reactivity. In 
general, modifications to the sidechain and to the sub- 
stituents on the ‘southern’ portion (see boxed regions, 
Fig. 1) of the molecule are poorly tolerated while changes 
to the ‘northern’ portion have little effect upon the drug’s 
activity (see unboxed regions, Fig. 1). Derivatization of 
the OH group at C-7 of the C-ring of the taxane nucleus 
to form an ester is usually well tolerated [34-361. The 
reactivity of taxol with electrophiles has been well studied 
[1,2]. The C-2’-hydroxyl of the sidechain is normally the 
most reactive and can be readily differentiated from the 
other hydroxyls. When C-2’ is protected, reaction usually 
proceeds selectively at the C-7 hydroxyl. It was therefore 
decided to derivatize the C-7 hydroxyl of taxol with an 
ester that contained a nascent pendant amine. Deutch’s 
group [37] has shown that o-amino esters of this alcohol 
are fairly unstable. We therefore decided to try to use the 
B-amino alanine ester as a general linker. To maximize the 
probability of producing a functional fluorescent taxoid, 
we explored several different conjugating groups and 
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Figure 3 
Synthesis of fluorescent taxoids 5a-d. 
Reagents and conditions: (a) dansyl chloride, 
triethylamine, acetonitrile, 25 “C, 10 min, 
69 O/o; (b) fluorescein N-hydroxysuccinate 
ester, 10 O/o aqueous sodium bicarbonate, 
dioxane, 25 “C, 1.2 h, 65 O/o; (c) carboxy-X- 
rhodamine N-hydroxysuccinate ester, 10 O/o 
aqueous sodium bicarbonate, dioxane, 25 “C, 
1.5 h, 73 O/o; (d) Lissamine Rhodamine B 
chloride, 10 O/o aqueous sodium bicarbonate, 
dioxane, 25 “C, 2 h. 
r 
5b: R = fluorescein fluorophore 
5c: R = carboxy-X-rhodamine fluorophore 
5d: R = Lissamine Rhodamine 6 fluorophore 
0 
OH 
Fluorescein fluorophore Dansyl fluorophore 
Carboxy-X-rhodamine fluorophore Lissamine Rhodamine B fluorophore 
tether lengths for the fluorophores. Because the presence 
of mixed isomers at the fluorophore’s aromatic nucleus 
does not affect the function of the material in fluores- 
cence microscopy, two of the fluorophores (fluorescein 
and carboxy-X-rhodamine) were introduced from the 
commercially available mixture of isomers. 
Results and discussion 
Synthetic chemistry 
With the synthetic goals in mind, taxol (compound 
1, Fig. 1) was reacted with benzyl chloroformate in 
the presence of pyridine to give the 2’-benzyl carbonate 
(compound 2, Fig. 2) of taxol in good (70 %) yield. This 
was then acylated with N-carboxybenzyl+alanine by 
treating the alcohol with dicyclohexylcarbodiimide and 
4-(N,N-dimethylamino)-pyridine to give the ester 3 (Fig. 
2) in high (95 %) yield. Concomitant reductive removal 
of both carboxybenzyl protecting groups gave the desired 
amine 4 (Fig. 2) in essentially quantitative yield. This 
amine was then conjugated with several f luorophores in 
good (65-73 %) yield to give the fluorescently labeled 
derivatives 5a-d (Fig. 3). 
As mixed isomers pose no problems for f luorescence 
microscopy, we did not separate the aromatic isomers of 
the fluorescein and carboxy-X-rhodamine conjugates. The 
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Table 1 
Physical properties of the fluorescent taxoids 5a-d. 
1 5a 5b 5c 5d 
Aqueous solubility (M) 
Partition coefficient 
(n-octanol/water) 
<<l x10-s <<I x10-a 4x 10-s 2x 10-a 1 x10-5 
>50 > 50 1 2 2 
Fluorescence maxima 350 I500 512 I550 400/610 380 I620 
(nm, excitation/emission) 550 I610 525 I620 
P-alanyl linker proves to be a good ‘handle’ for conjuga- microscopy. An interesting characteristic of the rhodamine 
tion of taxol. The method described above is efficient labeled taxoids 5c and 5d is that they developed a sec- 
enough (43-48 % overall yield from taxol) that it is possi- ondary excitation wavelength after conjugation to the 
ble to make fluorescent taxoids readily available in any taxoid nucleus. The combination of these characteristics 
reasonably anticipated quantities for most purposes. The was sufficiently promising to warrant further study. 
overall method should be easily adaptable to produce 
other taxol conjugates. Tubulin polymerization assays 
To test whether the addition of fluorescent groups had 
Physical properties impaired the activity of our modified taxoids, we exam- 
The solubility, stability, and spectroscopic characteristics ined their ability to polymerize chick brain tubulin in vitro 
of the fluorescently labeled taxoids were examined to (Fig. 4) [38]. The tubulin used in these assays retained 
determine their suitability for further study (Table 1). UV the microtubule-associated proteins (MAPS) [39,40]; this 
spectroscopic assays show that the three derivatives that system was viewed as more physiologically relevant. All 
contain formal charges, compounds 5b-d, are significantly the taxoids showed enhanced rates of tubulin polymeriza- 
more soluble in water than taxol. The dansyl taxoid 5a tion and a higher plateau for bulk polymerization levels 
retained taxol’s highly lipophilic character. The partition (as determined when the change of the absorbance 
coefficients (octanol to water) exhibited a similar shift reached the level of +O.OOZ/-0.004 A units per min) than 
towards hydrophilic character for the charged derivatives the DMSO control. Among the derivatives, the two rho- 
5b-d All the conjugates were reasonably stable in solution damine taxoids 5c and 5d exhibited the best tubulin poly- 
(>14 days at room temperature in ethanol (1 mM) with merization profiles, equaling that of the taxol control 
no apparent degradation). Finally, all conjugates retained within experimental error 20.002 OD. The fluorescein 
reasonable excitation/emission spectra (see Table 1) allow- labeled taxoid 5b had the next best tubulin-polymerizing 
ing the use of standard filter blocks for fluorescence ability and the dansyl derivative was least promising. 
Figure 4 
% 0.24 1’ 
” 
h 0.20 L 
. Taxol 
0 Taxoid 5a 
0 Taxoid 5b 
A Taxoid 5c 
0 Taxoid 5d 
. DMSO control 
(0.04); ; ; ; ; i. 1’2 1’4 1’6 i8 do 1, 
Time (min) 
Relative tubulin polymerization abilities of taxol 
and the fluorescent taxoids 5a-d. The bulk 
polymerization was determined by following 
the change in optical density at 340 nm 
spectroscopically. For particulars, see 
Materials and methods. 
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These results correlate directly with the partition coeffi- 
cients and aqueous solubility of the respective deriva- 
tives, perhaps indicating that profitable interaction with 
the microtubule requires a group on C-7 that retains the 
ability to hydrogen bond with bulk water. The observation 
that these derivatives are slightly less active than taxol is 
not unexpected, given previous results with other 
derivatizations at this position [32]. All of the fluorescent 
taxoids retain enough binding to microtubules that it is 
reasonable to expect them to be active in viva. 
Cytotoxicity assays 
To evaluate how well the fluorescently labeled taxoids 
retained their cytotoxicity, the derivatives were tested for 
their ability to inhibit the growth [41] of two cell lines: 
Chinese hamster ovary (CHO) and HeLa cervical carci- 
noma (HeLa) (Fig. 5). All the derivatives had significant 
entotoxic effects, though attenuated relative to taxol. This 
trend held for both cell lines, although the magnitude of 
growth inhibition was much lower in the CHO line (as 
expected since this cell line is normally less sensitive to 
taxoids than HeLa). The dansyl taxoid, 5a, showed the 
highest cytotoxicity. The two rhodamine derivatives (SC 





-3 -4 -5 -6 -7 -8 -9 
Log (IC 50 ) 
Relative cytotoxicities of taxol (I) and the fluorescent taxoids 5a-d. 
The cytotoxicities were determined using the standard XTT assay. For 
particulars, see Materials and methods. 
less than that of the dansyl taxoid, and the fluorescein 
derivative had the lowest cytotoxicity of the four. These 
results can not be directly related to either partition coeffi- 
cient or aqueous solubility. All the charged derivatives 
have lower cytotoxicities than the uncharged derivative 
or the taxol control, however. This may be because the 
Lissamine Red taxoid 5d (all cells have been fixed to allow comparison 
Microscopy images of human foreskin fibroblasts after exposure to 
with the controls). (a) DIC photomicrograph showing normal cellular 
morphology after 1 h exposure to the drug (20 FM, 37 “C). 
(b) Fluorescence photomicrograph of the same field shown in (a), using 
the rhodamine filter set, showing the fluorescence signal of the taxoid 5d. 
(c) Fluorescence photomicrograph of the same field shown in (a), using 
the fluorescein filter set, showing the microtubule cytoskeleton, as 
illuminated by traditional immunofluorescence using an oc-tubulin 
monoclonal. (d) DIC photomicrograph showing the abnormal cellular 
37 “C). (e) Fluorescence photomicrograph of the same field shown in (d) 
morphology that develops after 24 h exposure to taxoid 5d (20 pM, 
showing the fluorescence signal of the taxoid. Note the small structures 
of localized fluorescence (nucleoli marked by arrows) that do not appear 
in the immunofluorescence control. (0 Fluorescence photomicrograph of 
the same field shown in (d) showing the microtubule cytoskeleton by 
traditional immunofluorescence after 24 h exposure (note the absence of 
nucleoli). Clearly, in general the fluorescent taxoid reveals the same 
cytoskeletal structures as does traditional immunofluorescence. For 
experimental details, see Materials and methods. 
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Figure 7 
Confocal microscopy images of human 
foreskin fibroblasts after 1 h exposure to 
Lissamine Red taxoid 5d (20 FM, 37 “C, 
cells were fixed to allow comparison to the 
controls). The instrument was configured for 
blue to far red fluorescence excitation (458, 
568 and 647 nm) enabling three-color 
confocal imaging of cells directly. (a) The 
rhodamine signal. Note the high degree of 
detail revealed by the Lissamine taxoid 5d 
relative to the controls. (b) Electronic 
magnification (2x) of a portion of (a) showing 
the fine details that are visualized by taxoid 
5d. (c) Fluorescence photomicrographs of the 
same field shown in (a), using the fluorescein 
filter set, showing the fluorescence signal 
from a traditional immunofluorescence 
o-tubulin monoclonal). (d) Electronic 
magnification (2x) of a portion of (c). For 
experimental details, see Materials and 
methods 
charged derivatives diffuse less well across the hydropho- 
bic cell membrane, as observed previously with other 
charged derivatives at this position [42]. These results, 
combined with those from the experiments described 
above, clearly indicated that the rhodamine derivatives are 
the most promising for microscopy. 
Fluorescence microscopy 
We performed fluorescence microscopy experiments with 
three taxoids, the two rhodamine-labeled taxoids and the 
fluorescein-labeled one. These studies used cultured 
human foreskin fibroblasts, chosen because they become 
quiescent due to contact inhibition when well spread on 
the cover slips. In this state they have a clearly visible 
interphase array of microtubules. They therefore provide 
a good model for interphase cells, which these taxoids 
were designed to study. The fluorescein taxoid 5b exhib- 
ited rapid photobleaching and was not pursued further. 
Both the carboxy-X-rhodamine SC and Lissamine 5d 
taxoids had reasonable amplitudes of f luorescence and 
fluorescence lifetimes. Most of the microscopy studies 
were carried out using the Lissamine-labeled taxoid, 
because it has a slightly higher tubulin polymerization 
ability and cytotoxicity, a slightly cleaner f luorescence 
appearance, and the starting material for its chromophore 
is relatively inexpensive. 
When the cells were treated with fluorescent taxoid .5d, 
they began to display fluorescent cellular networks of 
microtubules after -10 min (Fig. 6b), a rate approximately 
equal to that with which fluorescently labeled tubulin is 
incoporated into the cytoskeleton. The micrographs shown 
in Figures 6 and 7 depict fixed cells to allow comparison 
between the fluorescent taxoid and the immunofluores- 
cence control. Similar images can be obtained with living 
cells (see Fig. 8). Double label f luorescence studies using 
the fluorescent taxoid and indirect immunofluorescence 
with anti-a-tubulin primary antibodies showed that the 
derivatives illuminate the same microtubule skeleton as 
does traditional immunofluorescence (Fig. 6c), and that the 
derivative does not block the binding of these antibodies 
to microtubules. The level of signal from the fluorescent 
taxoid 5d is higher than that from the antibody controls 
(see Fig. 7). The most likely explanation for this 
is that, under the experimental conditions employed, the 
taxoid (at 20 p,M) has saturated the binding sites of the 
microtubules (previously estimated at 10-20 PM, E.D. 
Salmon, personal communication) while the anti-ol-tubulin 
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antibody has not and therefore gives a weaker signal. 
There is also some evidence of a diffuse background signal 
that may represent unbound taxoid or agent bound to small 
tubulin oligomers. Given the degree of overall tubulin 
polymerization demonstrated by the Lissamine taxoid 5d 
z% vitro, it is more likely that the background signal is due 
to small oligomers. Thus, the net result of visualization 
with Lissamine taxoid 5d is a more richly detailed image 
than that provided by immunofluorescence. It is important 
to note that, unlike immunofluorescence images, these 
images can be obtained from living cells. 
Cells treated with fluorescent taxoids retained normal 
morphology (Fig. 6a) and microtubule networks (Fig. 6b) 
for -90-120 min, after which the cells appeared progres- 
sively abnormal by differential interference contrast (DIC) 
microscopy. After 20 h of treatment with the fluorescent 
derivative, the long extensions of the cells had retracted 
somewhat (Fig. 6d) and their microtubule networks 
appeared more bundled than filamentous (Fig. 6e). These 
results are as expected for a human cancer cell line treated 
with a taxoid. They demonstrate that the fluorescent con- 
jugation of taxol does not significantly perturb the behav- 
ior of these derivatives in living cells. It is therefore 
reasonable to assume that such compounds could be used 
to study taxol’s cellular mechanism of action. The syn- 
thetic chemistry described here is generally applicable to 
all taxoids containing a C-7 hydroxyl group, allowing this 
method of conjugation to be adapted to specific taxoids of 
interest. This class of derivatives should therefore enable 
workers to examine differences in the cellular behavior 
of specific taxoids with different physiological effects, 
especially in interphase cells. 
In the cells that had been treated with taxoids 5c and 5d 
for an extended period of time, some of the taxoid appears 
to have partitioned into structures that do not include 
tubulin. These structures include nucleoli (see those 
marked by arrows in Fig. 6e and 8) and, occasionally, small 
punctate objects. Immunofluorescence controls revealed 
no co-localization of a-tubulin antibodies for either type 
of partitioning and therefore, if these structures contain 
microtubules the tub&n epitope must no longer be 
accessible to the ol-tubulin antibody. 
The punctate structures that occasionally form in the 
cytoplasm may be small asters of microtubules; these are 
microtubule structures that have been observed by DIC 
microscopy in taxol-treated sea urchin eggs [43]. A more 
likely explanation for this phenomenon, however, is that 
the punctate structures are inclusion bodies into which the 
taxoids have been segregated in an effort to reduce their 
toxic effects. Taxol is more effective at killing cancer cells 
in vitro when administered as a slow infusion over 6-24 h 
[44]. It may be that inclusion body formation explains 
this empirical observation; perhaps inclusion bodies form 
Figure 8 
Competition between unlabeled taxol 1 and Lissamine-labeled taxoid 
5d for intracellular binding sites. The series of experiments shows that 
staining of the nucleoli is retained despite competition by unlabeled 
taxol. The figure depicts confocal microscopy images of human 
foreskin fibroblasts after 24 h exposure to a mixture of taxol 1 and 
Lissamine taxoid 5d (20 FM overall taxoid concentration, held constant 
in all experiments, 37 “C, cells are living and unfixed). The instrument 
was configured for far red fluorescence excitation. (a) The rhodamine 
signal generated by 100 %  Lissamine taxoid 5d. Note the staining of 
nucleoli (globular structures in the nucleus). (b) A 3:l mixture of taxol 1 
and Lissamine taxoid 5d. The relative level of signal between the 
microtubule based cytoskeleton and the nucleoli remains the same as 
in (a). (c) A 1 :l mixture of 1 and 5d. (d) A 1:3 mixture of 1 and 5d. The 
images in (c) and (d) were produced by photon accumulation and 
software control on the confocal microscope. This technique allowed 
the observation of the otherwise extremely weak overall fluorescence 
signal from the dilute Lissamine taxoid 5d. For experimental detail, see 
Materials and methods. 
only when too much drug is delivered in a given period. 
Alternatively, the fluorophore itself could be causing the 
segregation. A final possibility could be that the punctate 
structures are not securely fixed and are washed away 
during the immunofluorescence staining. 
The main fluorescence signal other than that due to 
tubulin distribution is the nucleolus which regularly 
exhibits fluorescence after exposure to 5d. There is no evi- 
dence for the presence of microtubules or tubulin in the 
nucleolus, but there is good evidence that one class of 
MAPS (the tau proteins) is present in the nucleolus of 
certain vertebrate tissue culture cells [45,46]. As the nucle- 
olus is not a membrane-bound organelle, the fact that the 
relatively hydrophobic taxoid 5d accumulates within it 
cannot be explained by partitioning of the hydrophobic 
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taxane into a membrane. In competition experiments with 
constant (20 p,M) levels of total taxol and decreasing pro- 
portions of labeled taxol 5d the relative levels of signal 
from the nucleolus and cytoskeleton remained constant 
(see Fig. 6). This result indicates that the binding of 
taxoid 5d to the nucleolus is as least as specific as its 
binding to the microtubule cytoskeleton. There are two 
reasonable explanations for this observation: there may be 
previously undetected tubulin subunits in the nucleolus 
itself during interphase, or the nucleolus may contain a 
previously undetected receptor for taxol other than micro- 
tubules. As the evidence against the presence of micro- 
tubules in the nucleus is strong, the second explaination 
seems most plausible. The potential of a new receptor for 
taxol raises interesting possibilities for further study. 
Significance 
The work presented above shows that the C-7 position of 
taxol can be substituted with a variety of groups attached 
via a P-alanyl ester linker. These studies have defined a 
general synthetic route to taxoids of this type that pro- 
ceeds with good overall yield. The method should easily 
adapt to the production of any labeled taxoid of interest. 
According to these studies, substitutions at the C-7 posi- 
tion of the taxane nucleus retain reasonable biological 
activity. In this study, we made a bioactive fluorescent 
derivative of taxol, 5d, that is useful for fluorescence 
microscopy. This derivative allows study of the micro- 
tubule-based cytoskeleton of living cells without using 
invasive techniques such as the microinjection of fluores- 
cently labeled proteins or the more severe fixation proce- 
dures required for immunofluorescence. The inherently 
high level of signal provided by using a large excess of a 
freely-diffusible specific fluorophore, such as 5d, provides 
a more detailed image than traditional immunofluores- 
cence. It is hoped that these derivatives will prove useful 
for researchers who are examining the dynamic proper- 
ties of microtubules in cells. In particular, we hope that 
these derivatives will enable studies of the effects of taxol 
in the relatively untouched area of interphase cells. These 
derivatives have already revealed the subcellular localiza- 
tion of taxoids to the nucleolus - an unanticipated and 
intriguing result. 
Materials and methods 
Chemistry 
General techniques 
All reactions were carried out in an argon atmosphere with freshly dried 
solvents under anhydrous conditions, unless otherwise noted. All 
reagents were purchased at highest commercial quality and used 
without further purification, unless otherwise stated. Preparative scale 
high performance liquid chromatography (HPLC) was carried out using 
a Vydak RP-18 (22.5 mm by 250 mm) column with a flow rate of 
9 ml min-’ and UV detection at 254 nm. NMR spectra were recorded 
on a Bruker AMX-500 instrument and calibrated using residual 
undeuterated solvent as an internal reference. The following abbrevia- 
tions were used: s, singlet; d, doublet; t, triplet; m, multiplet; band, 
several overlapping signals; br, broad. The carbon numbering of taxol 
was used to assign protons. Overlapping carbon signals were reported 
only once. Infrared (IR) spectra were recorded on a Perkin-Elmer 1600 
series FT-IR spectrometer. High resolution mass spectra (HRMS) were 
recorded on a VG ZAB-ZSE mass spectrometer under fast atom bom- 
bardment (FAB) conditions. 
2’Carboxybenzoyltaxol2 
A solution of taxol (1) (100 mg, 0.1 17 mmol) and pyridine (950 ~1, 
11.7 mmol, 100 equivalent (es.)) in methylene chloride (5 ml) at room 
temperature under argon was treated, at 10 min intervals, with benzyl 
chloroformate (170 t~,l aliquots, 1.17 mmol, 10 eq. to total of 60 eq.). 
When thin layer chromatography (TLC) (silica, 50 s/o EtOAc in hexanes, 
UV/PMA) showed no remaining starting material, the reaction was 
quenched with aqueous NH,CI (1 ml). After dilution with ethyl acetate 
(10 ml), the reaction mixture was washed with ammonium chloride 
(2 x 5 ml), copper sulfate (4 x 10 ml), and sodium chloride (5 ml). The 
combined organic layer was dried (Na,SO,), concentrated, and puri- 
fied by flash chromatography (silica, 50 O/o EtOAc in hexanes) to give 
2’carboxybenzoyltaxol as a white powder (80 mg, 70 %): F+ = 0.50 
(silica, 50 % EtOAc in hexanes); Tg (glass transition) = 152-l 54 “C; 
melting point (mp) = 206-210 “C; [elz4D -53.8 (c 0.01 g ml-r, CHCI,); 
IR (thin film) r+,,= 1240, 1371, 1724, 2962, 3511 cm-‘; ‘H NMR 
(500 MHz, CDCI,) 6, 1.14 (s, 3 H, 16-H) 1.25 (s, 3 H, 17-H) 1.69 (s, 
3 H, 19-H), 1.76 (s, 1 H, l-OH), 1.93 (s, 3 H, 18-H), 1.9-1.94 (m, 1 H, 
68-H) 2.2-2.3, 2.4-2.5 (m, 2 H, 14-H), 2.24 (s, 3 H, lo-OAc-H), 2.46 
(s, 3 H, 4-OAc-H), 2.51 (s, 1 H, 7-OH), 2.60 (m, 1 H, 6a-H), 3.82 (d, 
J= 7, 1 H, 3-H) 4.20 (d, J= 8.5, 1 H, 20-H, A of AB), 4.32 (d, J= 8.5, 
1 H, 20-H, B of AB), 4.41 (m, 1 H, 7-H), 4.98 (d, J= 8, 1 H, 5-H) 5.18 
(dd, J= 9,10, 2 H, Bn, AB), 5.45 (d, J= 2.5, 1 H, 2’-H), 5.69 (d, J = 7, 
1 H, 2-H), 5.98 (dd, J= 2.5, 9.5, 1 H, 3’-H), 6.30 (band, 2 H, 10-H, 13- 
H), 6.92 (d, J= 9.5, 1 H, NH), 7.30-7.42 (band, 12 H, Ar-H), 7.44-7.54 
(band, 3 H, Ar-H), 7.61 (t, J= 7, 1 H, Ar-H), 7.73 (d, J= 8.5, 2 H, Bz-H), 
8.14 (d, J=8.5, 2 H, Bz-H); 13C NMR (125 MHz, CDCI,) 6 9.5, 14.7, 
20.7, 22.0, 22.6, 26.7, 35.4, 35.5, 40.5, 44.4, 45.4, 52.6, 58.2, 70.7, 
71.9, 72.0, 74.9, 75.5, 76.3, 76.7, 78.1, 81.2, 84.3, 126.5, 127.0, 
128.3, 128.4, 130.1, 131.9, 132.1, 133.0, 134.0, 137.2, 142.5, 154.1, 
166.9, 167.2, 168.8, 171 .l, 204.1; FAB HRMS (NBAICsl) m/e found: 
1121.2852 (M + Cs+); calc’d for C,,H,,NO,,Cs: 1121.2810. 
2’-Carboxybenzoyl-7-(N-carboxybenzoyi-~-alany~-taxol3 
A solution of 2’carboxybenzoyltaxol 2 (25 mg, 0.025 mmol) and 4-(N,N- 
dimethylamino)pyridine (3 mg, 0.025 mmol, 1 eq.) in methylene chloride 
(2 ml) at room temperature under argon was treated with N-carboxyben- 
zoyl$-alanine (24 mg, 0.11 mmol, 4.4 eq.) and dicyclohexycarbodiimide 
(22 mg, 0.11 mmol, 4.4 eq.). After 18 h, the mixture was diluted with 
methylene chloride (5 ml) and filtered to remove the urea. The crude 
product was evaporated to dryness in KICUO and purified by flash chro- 
matography (silica, 40-45 % EtOAc in hexanes) to give 2’-carboxy- 
benzoyl-7-(N-carboxybenzoyl+&alanyl)-taxol as a white powder (28 mg, 
95 O/o): Rr = 0.55 (silica, 50 % EtOAc in hexanes); mp = 114-l 16 “C; 
[u]~~,, -45.7 (c 0.01 g ml-‘, CHCI,); IR (thin film) vrnax 1176, 1240, 
1372, 1651, 1728, 1747, 2936, 3401 cm-‘; ‘H NMR (500 MHz, 
CDCI,) 6, 1 .15 (s, 3 H, 16-H) 1.21 (s, 3 H, 17-H), 1.81 (s, 3 H, 19-H), 
1.99 (s, 3 H, 18-H) 2.06 (s, 3 H, IO-OAc-H), 2.21 (m, 1 H, 68-H), 
2.4-2.6 (band, 5 H, 14-H, 6e.-H, alanyl CH,), 2.46 (s, 3 H, 4-OAc-H), 
3.4-3.5 (m, 2 H, alanyl CH,), 3.96 (d, J= 7, 1 H, 3-H), 4.20 (d, J= 8.5, 
1 H, 20-H, A of AB), 4.33 (d, J= 8.5, 1 H, 20-H, B of AB), 4.95 (d, 
J=8.5, 1 H, 5-H) 5.18 (dd, J=9,10, 2 H, Bn, AB), 5.45 (d, J=2.5, 
1 H, 2’sH), 5.63 (dd, J= 5.7, 1 H, 7-H), 5.70 (d, J= 7, 1 H, 2-H), 5.98 
(dd, J= 2.5, 9, 1 H, 3’-H), 6.22-6.30 (band, 2 H, 10-H, 13-H), 6.98 (d, 
J = 9, 1 H, NH), 7.30-7.42 (band, 17 H, Ar-H), 7.43-7.52 (band, 3 H, Ar- 
H), 7.61 (t, J= 7, 1 H, Ar-H), 7.73 (d, J=8.5, 2 H, Bz-H), 8.14 (d, 
J= 8.5, 2 H, Bz-H); 13C NMR (125 MHz, CDCI,) 6 10.8, 14.4, 20.4, 
21.3, 22.5, 24.8, 25.5, 26.3, 33.3, 33.8, 34.2, 35.3, 43.1, 46.5, 48.2, 
52.7, 55.9, 66.3, 70.7, 71.4, 71.9, 74.4, 75.2, 76.6, 77.2, 78.5, 80.7, 
83.7, 126.5, 127.0, 127.8, 128.0, 128.4, 128.6, 128.8, 128.9, 130.1, 
131.9, 132.4, 133.4, 133.6, 136.6, 141.2, 153.9, 156.2, 166.8, 167.1, 
167.8, 169.4, 169.6, 171 .O, 202.1; FAB HRMS (NBA/Csl) m/e found: 
1326.3553 (M + Cs+); calc’d for C,sHssN,O,,Cs: 1326.3549. 
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7-P-alanyltaxol4 
A solution of compound 3 (25 mg, 0.021 mmol) in methanol (1 ml) at 
room temperature under argon was treated with 10 %  palladium on 
carbon (1 mg, 4 wt %) and placed under hydrogen. After 2 h, the 
mixture was filtered to remove the catalyst and evaporated to dryness 
in vacua to give 7-P-alanyltaxol 4 as a white powder (19 mg, quant.): 
mp = 215-218 “C; R, = 0.55 (silica, 10 %  MeOH in methylene chlo- 
ride); [alz4D -42.1 (c 0.01 g ml-‘, CHGI,); IR (thin film) vmax 1176, 
1240, 1412, 1662, 1716, 1765, 2990, 3301, 3482 cm-‘; ‘H NMR 
(500 MHz, CDsOD) 6, 1.09 (s, 3 H, 16-H), 1.16 (s, 3 H, 17-H), 1.78 (s, 
3 H, 19-H), 1.78-1.89 (m, 1 H, 6P-H), 1.87 (s, 3 H, 18-H), 1.91-2.00 
(m, 1 H, 14-H), 2.18 (s, 3 H, IO-OAc-H), 2.19-2.24 (m, 1 H, 14-H), 
2.38 (s, 3 H, 4-OAc-H), 2.50-2.59 (m, 1 H, Goi-H), 2.65-2.67 (m, 2 H, 
alanyl CH,), 3.12-3.22 (m, 2 H, alanyl CH,), 3.90 (d, J= 7, 1 H, 3-H) 
4.19 (dd, J= 7, 14, 2 H, 20-H), 4.73 (d, J=6, 1 H, 2/-H), 5.00 (d, 
J= 8.5, 1 H, 5-H), 5.63-5.65 (band, 3 H, 2-H, 3’-H, 7-H), 6.14 (br t, 
J = 6, 1 H, 13-H), 6.19 (s, 1 H, 1 O-H), 7.28-7.67 (band, 11 H, Ar-H, 
NH), 7.85 (dd, J= 1.5, 7.5, 2 H, Bz-H), 8.14 (dd, J= 1.5,7.5, 2 H, Bz- 
H); 13C NMR (125 MHz, CDsOD) 6 11.4, 14.7, 20.8, 22.1, 23.2, 25.4, 
26.7, 32.4, 36.3, 36.5, 44.6, 47.9, 49.2, 57.2, 57.7, 72.1, 73.6, 74.9, 
75.8, 76.9, 77.3, 78.8, 80.0, 81.8, 85.0, 128.5, 129.0, 129.6, 129.7, 
131.2, 132.9, 134.1, 134.7, 135.6, 139.9, 142.4, 167.6, 170.3, 171.3, 
171.8, 172.2, 174.5, 203.7; FAB HRMS (NBA/Csl) m/e found: 
1057.2765 (M + Cs+); calc’d for C,,H,,N,O,,Cs: 1057.2735. 
Dansyl taxoid 5a 
A solution of compound 4 (4.6 mg, 0.005 mmol) and triethylamine (1 ~1, 
0.0075 mmol, 1.5 eq.) in acetonitrile (1 ml) at room temperature under 
argon was treated with dansyl chloride (2 mg, 0.007 mmol, 1.4 eq). 
After 10 min, the solvent was removed in vacua and the residue was 
purified by flash chromatography (silica, 50 %  EtOAc in hexanes) to 
give 5a as a white powder (4 mg, 69 o/o): mp = 208-210 “C; R, = 0.29 
(silica, 50 O/o EtOAc in hexanes); IR (thin film) I),,,~~ 1096, 1382, 1474, 
1522, 1744, 1748, 1793, 2958, 3109 cm-‘; ‘H NMR (500 MHz, 
CDCI,) 6, 1 ,12 (s, 3 H, 16-H), 1 .19 (s, 3 H, 17-H), 1.73 (s, 3 H, 19-H), 
1.78 (s, 3 H, 18-H),1.91-2.00, (m, 1 H, 6P-H), 2.15 (s, 3 H, lo-OAc- 
H), 2.22-2.30 (m, 2 H, 14-H), 2.37 (s, 3 H, 4-OAc-H), 2.50-2.59, (m, 1 
H, 601-H), 2.86 (s, 6 H, NMe-H), 3.20 (m, 2 H, alanyl CH,), 3.41-3.49 
(m, 2 H, alanyl CH,), 3.86 (d, J= 7, 1 H, 3-H), 4.14 (d, J= 8, 1 H, 20- 
H, A of AB), 4.29 (d, J= 8, 1 H, 20-H, B of AB), 4.79 (b m, 1 H, 2’-H), 
4.87 (d, J= 9, 1 H, 5-H), 5.50 (dd, J= 7, 10, 1 H, 7-H), 5.64 (d, J= 7, 1 
H, 2-H), 5.77 (dd, J= 2.5, 8, 1 H, 3/-H), 5.87 (br t, J= 6, 1 H, 13-H), 
6.17 (s, 1 H, 10-H), 6.18 (brm, 1 H, NH), 7.02 (d,J=9, 1 H, NH), 7.16 
(d, 1 H, J= 7.5, Ar-H), 7.29-7.60 (m, 13 H, Ar-H), 7.74 (d, J= 7.5, 2 H, 
Bz-H), 8.09 (d, J= 7.5, 2 H, Bz-H), 8.22 (d, J= 7.5, 1 H, Ar-H), 8.31 (d, 
J= 8.5, 1 H, Ar-H), 8.50 (d, J=8.5, 1 H, Ar-H); 13C NMR (125 MHz, 
CDCI,) 6 9.4, 10.7, 14.5, 20.7, 20.8, 20.8, 22.4, 24.8, 25.5, 26.4, 29.6, 
33.2, 33.8, 33.9, 35.4, 38.1, 43.0, 45.3, 46.6, 49.0, 54.8, 55.9, 66.4, 
71.6, 72.1, 73.0, 74.1, 75.2, 78.4, 80.6, 83.6, 115.0, 119.0, 123.1, 
126.9, 128.0, 128.3, 128.6, 128.9, 128.9, 129.0, 129.6, 129.8, 130.0, 
131.9, 132.7, 133.5, 133.7, 135.2, 137.8, 140.5, 151.7, 166.8, 169.8, 
170.3, 170.8, 172.4, 201.8; FAB HRMS (NBAICSI) m/e found: 
1290.3288 (M + Cs+); calc’d for C,,Hs,N,SO,,Cs: 1290.3246. 
Fluorescein taxoid 5b 
A solution of compound 4 (7.4 mg, 0.008 mmol) in 1 :l dioxane:saturated 
aqueous sodium bicarbonate (1 ml) at room temperature under argon 
was treated with 6-(fluorescein-5-(and 6)-carboxamidehexanoic acid suc- 
cinimidyl ester (5 mg, 0.009 mmol, 1 .l eq). After 1.2 h, the solvent was 
removed in vacua and the residue was purified by flash chromatography 
(silica, 1 %  AcOH and 10 %  MeOH In methylene chloride) to give 5b as 
a yellow film (7 mg, 65 O/o): mp = 300 “C (dec.); &= 0.41 (silica, 1 O/o 
AcOH and 10 O/o MeOH in methylene chloride); IR (thin film) vmaX 11 12, 
1451,1620,1728,1734,2980,3000,3401 cm-‘; ‘H NMR (500 MHz, 
1:l CDCI,:CD,OD) 6, 0.93 (s, 3 H, 16-H), 0.97 (s, 3 H, 17-H), 
1 .15-l .22 (m, 2 H, CH,), 1.40-l .50 (m, 4 H, CH,), 1.59 (s, 3 H, 19-H), 
1.60-1.63 (m, 1 H, 6P-H), 1.79 (s, 3 H, 18-H), 1.97 (s, 3 H, IO-OAc-H), 
1.98-2.03 (m, 4 H, CH,), 2.08-2.16 (m, 2 H, 14-H), 2.17 (s, 3 H, 4- 
OAc-H), 2.26-2.40 (band, 3 H, Goi-H, CH,), 3.16-3.30 (m, 2 H, alanyl 
CH,), 3.69 (d, J= 7, 1 H, 3-H), 4.01 (d, J= 8.5, 1 H, 20-H, A of AB), 
4.09 (d, J= 8.5, 1 H, 20-H, B of AB), 4.55 (brm, 1 H, 2’.H), 4.74 (d, 
J= 9, 1 H, 5-H), 5.38 (dd, J= 7, 10, 1 H, 7-H), 5.48 (d, J= 7, 1 H, 2-H), 
5.50 (m, 1 H, 3’-H), 5.96 (br t, J=9, 1 H, 13-H), 6.03 (s, 1 H, 10-H), 
6.28-6.39 (band, 4 H, ArH), 6.98 (br t, J= 7, 1 H, NH), 7.02 (d, J= 8, 1 
H, Ar-H), 7.10 (m, 1 H, N-H), 7.15-7.32 (band, 10 H, Ar-H, NH), 7.57 (d, 
J= 7.5, 2 H, Ar-H), 7.89 (d, J= 7.5, 2 H, Bz-H), 7.97 (dd, J= 1.5, 7, 2 H, 
Ar-H), 8.15 (bt, J= 6, 1 H, Ar-H), 8.21 (s, 1 H, Ar-H); 13C NMR 
(125 MHz, 1:l CDCI,:CDsOD) 6 11.0, 14.0, 20.8, 21.0, 22.5, 24.6, 
25.9, 26.0, 28.2, 33.1, 33.2, 33.9, 34.0, 35.1, 35.7, 35.8, 39.1, 39.3, 
39.5, 39.9, 43.3, 47.2, 50.8, 51.0, 55.1, 56.0, 72.2, 72.3, 72.8, 74.0, 
75.3, 76.1, 79.8, 80.7, 83.2, 102.5, 126.4, 127.2, 128.0, 128.1, 128.2, 
128.3,128.3, 128.4, 129.4, 131.8, 132.4, 133.0, 140.7, 141.2, 166.4, 
166.6, 170.0, 171.0, 178.8, 199.1, 202.4; FAB HRMS (NBAKsI) m/e 
found: 1528.4010 (M + Cs+); calc’d for C,,H,,N,O,,Cs: 1528.4053. 
Carboxyrhodamine taxoid 5c 
A solution of compund 4 (7.4 mg, 0.008 mmol) in 1:1 dioxane:satu- 
rated aqueous sodium bicarbonate (1 ml) at room temperature under 
argon was treated with (5-(and 6-)carboxysuccinimidyl ester)-2-car- 
boxyrhodamine (6 mg, 0.009 mmol, 1.1 eq). After 1.5 h, the solvent 
was removed in vacua and the residue was purified by HPLC (a gradi- 
ent of 80 %  20 mM ammonium acetate in methanol to 100 O/o methanol 
over 30 min) to give 5b as a red film (8 mg, 73 O/o): mp = 252-256 “C 
(dec.); R, = 0.58 (silica, 1 O/o AcOH and 10 %  MeOH in methylene 
chloride); IR (thin film) vmaX 1064, 1156, 1550, 1601, 1720, 1756, 
2986,369O cm-’ ; ‘H NMR (500 MHz, CDsOD) 6,0.85-0.95 (m, 4 H, 
CH,), 1.06 (s, 3 H, 16-H), 1.14 (s, 3 H, 17-H), 1.20-1.41 (m, 4 H, 
CH,), 1.76 (s, 3 H, 19-H), 1.89 (s, 3 H, 18-H), 2.05 (m, 1 H, 6P-H), 
2.06 (m, 2 H, CH,), 2.09 (s, 3 H, lo-OAc-H), 2.35 (s, 3 H, 4-OAc-H), 
2.51-2.70 (band, 3 H, CH,, Goi-H), 3.01-3.04 (m, 2 H, CH,), 
3.41-3.71 (m, 6 H, CH,),3.91 (d, J=7, 1 H,3-H),4.16 (d, J=8.5, 1 
H, 20-H, A of AB), 4.28 (d, J= 8.5, 1 H, 20-H, B of AB), 4.48 (brm, 1 
H, 2/-H), 4.74 (d, J= 9, 1 H, 5-H), 5.60 (band, 3 H, 2-H, 3’-H, 7-H), 
6.12 (brt,J=9, 1 H, 13-H), 6.22 (s, 1 H, 10-H), 6.73 (d, J=7.5, 1 H, 
Ar-H), 7.25 (br t, J= 9, 1 H, NH), 7.40-7.72 (band, 13 H, ArH), 7.81 (d, 
J= 8, 1 H, Ar-H), 8.00 (d, J= 9, 1 H, Ar-H), 8.12 (d, J= 7.5, 2 H, Ar- 
H), 8.44 (s, 1 H, Ar-H); 13C NMR (125 MHz, CD,OD) 6 11.0, 13.1, 
14.7, 20-21 (m), 22.0, 25.1, 25.3, 28-29 (m), 30.2, 31.3, 43.0, 50.1, 
51.5, 55.1, 56.0, 65.1, 100.2, 104.7, 110.6, 111.3, 114.0, 119.3, 
122.4, 124.0, 125.7, 126.0, 126.4, 127.0, 127.1, 127.3, 128.2, 129.0, 
130.3, 131.4, 133.2, 133.4, 134.7, 151.2, 152.0, 158.0, 166.3, 168.0, 
169.2, 171 .l, 173.4, 206.2; positive electrospray m/e found: 1442.6, 
(M + H+); calc’d for CssHssN,O,,: 1442.0. 
Sulforhodamine (Lissamine Red) taxoid 5d 
A solution of compound 4 (19 mg, 0.021 mmol) in 1:1 dioxane:satu- 
rated aqueous sodium bicarbonate (1.5 ml) at room temperature under 
argon was treated with 6-chlorosulfonyl-2-sulfoxytetraethyl-rhodamine 
(Lissamine Rhodamine B chloride) (I 5 mg, 0.026 mmol, 1.25 eq). After 
2 h, the mixture was diluted with aqueous sodium chloride (5 ml) and 
extracted (10 x 10 ml) with ethyl acetate. The combined organic layer 
was evaporated and the residue purified by HPLC (a gradient of 80 O/o 
20 mM ammonium acetate in methanol to 100 %  methanol over 
30 min) to give compound 5b as a deep purple film (22 mg, 75 O/o): 
mp > 300 “C; R, = 0.54 (silica, 1 O/o AcOH and 10 %  MeOH in methy- 
lene chloride); IR (thin film) v,,,~ 1064, 1156, 1550, 1601, 1720, 
1756, 2986, 3690 cm-‘; ‘H NMR (500 MHz, CD,OD) 6, 0.97 (s, 3 H, 
16-H), 1 .Ol (s, 3 H, 17-H), 1 .16 (m, 12 H, CH,CH,N), 1.61 (s, 3 H, 
19-H), 1.61-1.64 (m, 1 H, 6P-H), 1.74 (s, 3 H, 18-H), 1.81-1.85 (m, 1 
H, 14-H), 2.04 (s, 3 H, lo-OAc-H), 2.03-2.12 (m, 1 H, 14-H), 2.21 (s, 
3 H, 4-OAc-H), 2.33-2.47 (band, 3 H, CH,, 6~H), 3.1 O-3.1 8 (m, 2 H, 
CH,), 3.53 (br t, 8 H, J= 7, CH,N), 3.76 (d, J= 7, 1 H, 3-H), 4.06 (dd, 
J= 8.5, 12, 2 H, 20-H, AB), 4.60 (d, J= 5, 1 H, 2’.H), 4.85 (d, J= 9, 1 
H, 5-H), 5.42-5.5 (band, 3 H, 2-H, 3’-H, 7-H), 6.01 (br t, J= 9, 1 H, 
13-H), 6.09 (s, 1 H, 10-H), 6.80 (brs, 2 H, Ar-H), 6.84 (m, 2 H, Ar-H), 
6.97 (m, 2 H, Ar-H), 7.17 (br t, J= 9, 1 H, NH), 7.22-7.43 (band, 12 H, 
ArH), 7.53 (m, 1 H, Ar-H), 7.72 (d, J= 8, 1 H, Ar-H), 8.01 (d, J= 9, 1 H, 
Ar-H), 8.03 (dd, J= 2, 7, 1 H, At=H), 8.54 (br s, 1 H, Ar-H); 13C NMR 
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(125 MHz, CDsOD) 6 11.6, 12.9, 14.8, 21.0, 22.8, 23.6, 26.7, 34.2, 
35.4, 36.2, 39.0, 44.6, 46.8, 47.2, 56.9, 57.8, 72.3, 73.4, 74.9, 76.0, 
77.1, 77.4, 78.5, 82.1, 85.3, 97.0, 115.0, 115.1, 116.0, 116.1, 127.5, 
128.5, 129.0, 129.4, 129.6, 129.8, 131.2, 131.3, 132.0, 132.9, 133.1, 
133.2, 133.9, 133.9, 134.4, 135.5, 135.6, 140.0, 142.5, 144.0, 147.3, 
157.2, 157.3, 158.0, 159.6, 167.6, 170.6, 171.0, 171.3, 172.1, 174.3, 
204.0; positive electrospray m/e found: 1487.0 (M + H+); calc’d for 
C,,H,,N,S,O,,: 1487.0. 
Solubility measurements 
The taxoid (1 mg) was placed in a 2-ml Eppendorf tube and suspended 
in deionized water (1 ml) with the aid of sonication for 5 min. The tubes 
were spun at 14 000 rpm for 1 min in a microcentrifuge to settle par- 
ticulate matter. The solution was then carefully removed and filtered 
through a syringe filter (DuPont, 0.45 km PTFE). Solubility was deter- 
mined by measuring the UV absorbance of an aliquot of the aqueous 
solution at 254 nm and comparing to a standard curve produced by 
standard dilution of a 1 mM solution of the taxoid in methanol. 
Partition coefficient 
After the solubility of the taxoid was measured as above, the solution 
was replaced in the original Eppendorf tube, nonanol (1 ml) was added, 
and the mixture shaken vigorously for 5 min. The tubes were centrifuged 
to settle any particulate matter and the layers were separated. Partition 
coefficients were determined by comparing the UV absorbance of the 
layers at 254 nm. 
Stability 
The stability of the taxoids was measured by thin layer chromatography 
of a 1 mM solution in ethanol. The solutions were kept at ambient tem- 
perature under air and the purity checked each day. The experiment was 
discontinued after two weeks when no significant degradation was 
detected. The stability was confirmed by examining the ‘H NMR spectra 
of each compound at the end of the experiment. 
Biology 
Cytotoxicity measurements 
Cells (ATTC HeLa and CHO, 1250 per well) were plated on 96-well 
plates in RPMI media with fetal calf serum (FCS) (245 ~1 per well) and 
grown to -50 % confluence (24 h). The taxoids were diluted in ethanol 
and added as 5 ~1 aliquots directly to the wells to give final concentra- 
tions ranging from 1 x 10m4 to 1 x lo-lo M for each compound. The 
experimental controls were ethanol (5 ~1) as the negative cytotoxicity 
control and sodium dodecylsulfate (1 x 1 Oe3 M final concentration) as 
the positive cytotoxicity control. The growth inhibition was determined 
using the standard XTT assay [41 I. 
Tubulin polymerization assays 
Microtubules were prepared from the brains of l-3 day old baby chicks 
(Hall Bros. Hatchery, Norwich, CT) by the standard double polymeriza- 
tion-depolymerization cycling in PM buffer [39,471. On the day of a poly 
merization experiment, the microtubules and overlay buffer were thawed 
quickly. As the buffer thawed, the pellet was resuspended in the overlay 
buffer by gentle trituration with a Pasteur pipet. A final round of assembly 
at 37 “C followed by disassembly and clarification at 4 “C was performed 
to select for assembly competent protein after the period of storage. The 
resulting solution of 3x assembled microtubules (tubulin plus MAPS) was 
used in the assembly experiments reported herein. Polymerization assays 
were carried out on three-cycled tubulin in PIPES buffer (100 mM, 
pH 6.9) containing GTP (2 mM), MgSO, (5 mM), and EGTA (1 mM) 
[41]. The protein was not further purified and thus retained the MAPS. 
The tubulin solution was treated with taxoid (10 PM) and allowed to 
polymerize at 37 “C while the optical density was monitored at 340 nm. 
Microscopy 
Human foreskin fibroblasts were treated at 37 “C with taxoids at 20 PM, 
a concentration that is equimolar with that of cellular tubulin (E.D. 
Salmon, personal communication). After 1 h or 24 h, cells were observed 
with a Zeiss Axiophot microscope using differential interference contrast 
and fluorescence optics via a 40x 1.3 N.A. objective or a 100x 1.4 N.A. 
objective. Color micrographs were recorded on Kodak Ektachrome 
exposed at an ASA of 400 and developed commercially. Confocal micro- 
scope images were generated by a BioRad MRC 1000 operating on 
a Nikon microscope with a 63x 1.4 N.A. objective and captured electron- 
ically and stored on magnetic media. Composite color figures were 
produced either from stored electronic images or by scanning color pho- 
tographs and manipulating the resulting files with Adobe Photoshop. 
Cells were fixed first in 3.7 o/, formaldehyde in PBS (phosphate buffered 
saline, pH 7.0) for 15 min at room temperature and then in 100 % 
methanol at -20 for 10 min. Following the methanol fixation and perme- 
ablization step, the cells were rehydrated in PBS and then stained with a 
monoclonal antibody to OL tubulin (Sigma Chemical Co.) followed by the 
appropriate fluorescent secondary antibody (Kirkegaard and Perry, Inc.). 
Both the primary and secondary antibodies were used at the dilutions 
recommended by the respective suppliers of the antibodies. For images 
of living cells, the fixation and permeabilization steps were omitted. 
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